Cash and Cash Equivalents, at Carrying Value of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was $37,284, a 61% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $37,284 +$14,180 +61% 31 Dec 2024 20-F 13 Jun 2025 2024 FY
Q4 2023 $23,104 +$16,476 +249% 31 Dec 2023 20-F/A 23 Sep 2025 2023 FY
Q3 2023 $16,911 30 Sep 2023 6-K 13 Nov 2023 2023 Q3
Q4 2022 $6,628 -$93,056 -93% 31 Dec 2022 20-F/A 23 Sep 2025 2023 FY
Q4 2021 $99,684 +$99,390 +33806% 31 Dec 2021 20-F 15 May 2023 2022 FY
Q4 2020 $294 31 Dec 2020 20-F 15 May 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.